Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1125.3000 -5.00 (-0.44%)
NSE Oct 13, 2025 09:44 AM
Volume: 96,732
 

1125.30
-0.44%
HDFC Securities
Aurobindo Pharma Ltd Q2FY19 results Comment Revenue grew by 11.61% to Rs. 4667.12 Cr in Q2FY19 when compared to the previous quarter. Also, it increased by 7.19% when compared with Q2FY18.
Aurobindo Pharma Ltd. is trading above its 100 day SMA of 1110.8
More from Aurobindo Pharma Ltd.
Recommended